RxDoctor Payments Data

Nakayla Chan

Physician Assistant · Las Vegas, NVNPI 1407488653

Payments from drug & device makers

$2,197in general payments, 2019–2025

Across 62 payments — averaging $35.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$433
  • Regeneron Healthcare Solutions, Inc.$249
  • Sanofi$186
  • GSK$184
  • Getinge USA Sales, LLC$162
  • Edwards Lifesciences$136
  • plus $847 from 15 others

What the payments were for

  • Food & beverage$2,14498%
  • Education$532%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,197 in reported general payments places this provider in the 75th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada

Most prescribed under Part D

DrugClaimsCost to plans & patients
XhanceFluticasone Propionate16$14,327
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav101$911
Methylprednisolone118$658
Fluticasone Propionate63$616
Mupirocin55$388
Ciprofloxacin Hcl21$152
Azithromycin20$119
Doxycycline Hyclate11$101
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim20$53
Triazolam12$36

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Optinose US, Inc.Xhance$28$14,32716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 881 physician assistant providers in Nevada.

Other physician assistant in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →